Advertisement

Learning by Difference: Placebo Effects and Specific Efficacy in Pharmacological RCTs

  • Marco AnnoniEmail author
  • Giovanni Boniolo
Chapter
  • 23 Downloads
Part of the Boston Studies in the Philosophy and History of Science book series (BSPS, volume 338)

Abstract

The logic underpinning randomized controlled trials depends on the assumption that any non-specific effects of treatment are equal and additive across trial arms. We label this the “assumption of specific efficacy”. There are a number of situations in which the assumption of specific efficacy does not hold. We describe the epistemic consequences that arise in these situations and discuss strategies for preserving the internal validity of randomized trials in such situations.

References

  1. Annoni, M. (2013). Highlights from the 2013 science of placebo thematic workshop. Ecancermedicalscience, 4(7), 346.Google Scholar
  2. Benedetti, F. (2009). Placebo effects: Understanding the mechanisms in health and disease. New York: Oxford University Press.Google Scholar
  3. Benedetti, F. (2010). The Patient’s brain. Oxford: Oxford University Press.  https://doi.org/10.1093/med/9780199579518.001.0001.CrossRefGoogle Scholar
  4. Benedetti, F., Maggi, G., Lopiano, L., Lanotte, M., Rainero, I., Vighetti, S., & Pollo, A. (2003). Open versus hidden medical treatments: The patients knowledge about a therapy affects the therapy outcome. Prevention & Treatment, 6(1), 1–19.  https://doi.org/10.1037/ 1522-3736.6.0001a.CrossRefGoogle Scholar
  5. Boutron, I., Estellat, C., & Ravaud, P. (2005). A review of blinding in randomized controlled trials found results inconsistent and questionable. Journal of Clinical Epidemiology, 58(12), 1220–1226.  https://doi.org/10.1016/j.jclinepi.2005.04.006.CrossRefGoogle Scholar
  6. Colagiuri, B. (2010). Participant expectancies in double-blind randomized placebo-controlled trials: Potential limitations to trial validity. Clinical Trials: Journal of the Society for Clinical Trials, 7(3), 246–255.  https://doi.org/10.1177/1740774510367916.CrossRefGoogle Scholar
  7. Colloca, L., & Miller, F. G. (2011). The nocebo effect and its relevance for clinical practice. Psychosomatic Medicine, 73(7), 598–603.  https://doi.org/10.1097/psy.0b013e3182294a50.CrossRefGoogle Scholar
  8. Colloca, L., & Nestoriuc, Y. (2016). Nocebo and the PatientPhysician communication. In Ethical counselling and medical decision-making in the era of personalised medicine (SpringerBriefs in applied sciences and technology) (pp. 29–37). Cham: Springer.  https://doi.org/10.1007/978-3-319-27690-8_4.CrossRefGoogle Scholar
  9. Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004). Overt versus covert treatment for pain, anxiety, and Parkinsons disease. The Lancet Neurology, 3(11), 679–684.  https://doi.org/10.1016/s1474-4422(04)00908-1.CrossRefGoogle Scholar
  10. Colloca, L., Sigaudo, M., & Benedetti, F. (2008). The role of learning in Nocebo and placebo effects. Pain, 136(1), 211–218.  https://doi.org/10.1016/j.pain.2008.02.006.CrossRefGoogle Scholar
  11. Colloca, L., Flaten, M. A., & Meissner, K. (2013). Placebo and pain: From bench to bedside. Amsterdam: Academic.Google Scholar
  12. Enck, P., Klosterhalfen, S., Weimer, K., Horing, B., & Zipfel, S. (2011). The placebo response in clinical trials: More questions than answers. Philosophical Transactions of the Royal Society B: Biological Sciences, 366(1572), 1889–1895.  https://doi.org/10.1098/rstb.2010.0384.CrossRefGoogle Scholar
  13. Fergusson, D. (2004). Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ, 328(7437), 432–430.  https://doi.org/10.1136/bmj.37952.631667.ee.CrossRefGoogle Scholar
  14. Grünbaum, A. (1981). The placebo concept. Behaviour Research and Therapy, 19(2), 157–167.  https://doi.org/10.1016/0005-7967(81)90040-1.CrossRefGoogle Scholar
  15. Grünbaum, A. (1985). Explication and implications of the placebo concept. In L. White, B. Tursky, & G. E. Schwartz (Eds.), Placebo: Theory, research and mechanisms (pp. 9–36). New York: Guilford Press.Google Scholar
  16. Grünbaum, A. (1986). The placebo concept in medicine and psychiatry. Psychological Medicine, 16(01), 19–38.  https://doi.org/10.1017/s0033291700002506.CrossRefGoogle Scholar
  17. Haake, M. (2007). German acupuncture trials (Gerac) for chronic low back pain. Archives of Internal Medicine, 167(17), 1892–1898.  https://doi.org/10.1001/archinte.167.17.1892.CrossRefGoogle Scholar
  18. Hammami, M. M., Al-Gaai, E. A., Alvi, S., & Hammami, M. B. (2010). Interaction between drug and placebo effects: A cross-over balanced placebo design trial. Trials, 11(1).  https://doi.org/10.1186/1745-6215-11-110.
  19. Holman, B. (2015). Why most sugar pills are not placebos. Philosophy of Science, 82(5), 1330–1343.  https://doi.org/10.1086/683817.CrossRefGoogle Scholar
  20. Howick, J. (2011). The philosophy of evidence-based medicine. Wiley-Blackwell.  https://doi.org/10.1002/9781444342673.
  21. Howick, J. (2016). The relativity of “placebos”: Defending a modified version of Grünbaum’s definition. Synthese, 194(4), 1363–1396.  https://doi.org/10.1007/s11229-015-1001-0.CrossRefGoogle Scholar
  22. Hróbjartsson, A., Forfang, E., Haahr, M., Als-Nielsen, B., & Brorson, S. (2007). Blinded trials taken to the test: An analysis of randomized clinical trials that report tests for the success of blinding. International Journal of Epidemiology, 36(3), 654–663.  https://doi.org/10.1093/ije/dym020.CrossRefGoogle Scholar
  23. Hughes, J. R., Gulliver, S. B., Amori, G., Mireanlt, G. C., & Fenwick, J. F. (1989). Effect of instructions and nicotine on smoking cessation, withdrawal symptoms and self-Administration of nicotine gum. Psychopharmacology, 99(4), 486–491.  https://doi.org/10.1007/bf00589896.CrossRefGoogle Scholar
  24. Kaptchuk, T. J., Stason, W. B., Davis, R. B., Legedza, A. R. T., Schnyer, R. N., Kerr, C. E., Stone, D. A., Nam, B. H., Kirsch, I., & Goldman, R. H. (2006). Sham device V inert pill: Randomised controlled trial of two placebo treatments. BMJ, 332(7538), 391–397.  https://doi.org/10.1136/bmj.38726.603310.55.CrossRefGoogle Scholar
  25. Kirsch, I. (1997). Specifying non-specifics: Psychological mechanisms of placebo effects. In A. Harrington (Ed.), The placebo effect: An interdisciplinary exploration. Cambridge, MA: Harvard University Press.Google Scholar
  26. Kirsch, I. (2000). Are drug and placebo effects in depression additive? Biological Psychiatry, 47(8), 733–735.  https://doi.org/10.1016/s0006-3223(00)00832-5.CrossRefGoogle Scholar
  27. Kirsch, I. (2010). The Emperor’s new drugs: Exploding the antidepressant myth. New York: Basic Books.Google Scholar
  28. Kirsch, I., & Weixel, L. J. (1988). Double-blind versus deceptive administration of a placebo. Behavioral Neuroscience, 102(2), 319–323.  https://doi.org/10.1037//0735-7044.102.2.319.CrossRefGoogle Scholar
  29. Levine, J. D., & Gordon, N. C. (1984). Influence of the method of drug administration on analgesic response. Nature, 312(5996), 755–756.  https://doi.org/10.1038/312755a0.CrossRefGoogle Scholar
  30. Martin, A. L., & Katz, J. (2010). Inclusion of authorized deception in the informed consent process does not affect the magnitude of the placebo effect for experimentally induced pain. Pain, 149(2), 208–215.  https://doi.org/10.1016/j.pain.2009.12.004.CrossRefGoogle Scholar
  31. Miller, Franklin G, Luana Colloca, R. A. Crouch, and T. J. Kaptchuk, eds. 2013. The placebo: A reader. Baltimore: The Johns Hopkins University Press.Google Scholar
  32. Miller, F. G., Wendler, D., & Swartzman, L. C. (2005). Deception in research on the placebo effect. PLoS Medicine, 2(9), e262.  https://doi.org/10.1371/journal.pmed.0020262.CrossRefGoogle Scholar
  33. Ney, P. G., Collins, C., & Spensor, C. (1986). Double blind: Double talk or are there ways to do better research. Medical Hypotheses, 21(2), 119–126.  https://doi.org/10.1016/0306-9877(86)90001-0.CrossRefGoogle Scholar
  34. Pahnke, W. N. (1966). Drugs and mysticism. International Journal of Parapsychology, 8(2), 295–313.Google Scholar
  35. Pollo, A., Amanzio, M., Arslanian, A., Casadio, C., Maggi, G., & Benedetti, F. (2001). Response expectancies in placebo analgesia and their clinical relevance. Pain, 93(1), 77–84.  https://doi.org/10.1016/s0304-3959(01)00296-2.CrossRefGoogle Scholar
  36. Randall, L. O., Heise, G. A., Schallek, W., Bagdon, R. E., Banziger, R., Boris, A., Moe, R. A., & Abrams, W. B. (1961). Pharmacological and clinical studies on valium (TM) a new psychotherapeutic agent of the benzodiazepine class. Current Therapeutic Research, Clinical and Experimental, 3, 405.Google Scholar
  37. Roelofs, P. D., Deyo, R. A., Koes, B. W., Scholten, R. J. P. M., & van Tulder, M. W. (2008). Nonsteroidal anti-inflammatory drugs for low Back pain. Spine, 33(16), 1766–1774.  https://doi.org/10.1097/brs.0b013e31817e69d3.CrossRefGoogle Scholar
  38. Ross, S., Krugman, A. D., Lyerly, S. B., & Clyde, A. D. J. (1962). Drugs and placebos: A model design. Psychological Reports, 10(2), 383–392.  https://doi.org/10.2466/pr0.1962.10.2.383.CrossRefGoogle Scholar
  39. Sackett, D. L. (2007). Commentary: Measuring the success of blinding in RCTs: Dont, must, cant or Neednt? International Journal of Epidemiology, 36(3), 664–665.  https://doi.org/10.1093/ije/dym088.CrossRefGoogle Scholar
  40. Schulz, K. F., & Grimes, D. A. (Eds.). (2006). The Lancet handbook of essential concepts in clinical research. Spain: Elsevier.Google Scholar
  41. Shapiro, A. K., & Morris, L. A. (1978). The placebo effect in medical and psychological therapies. Handbook of Psychotherapy and Behavior Change, 2, 369–409.Google Scholar
  42. Teira, D. (2013). Blinding and the non-interference assumption in medical and social trials. Philosophy of the Social Sciences, 43(3), 358–372.  https://doi.org/10.1177/0048393113488871.CrossRefGoogle Scholar
  43. Walach, H. (2001). The efficacy paradox in randomized controlled trials of CAM and elsewhere: Beware of the placebo trap. The Journal of Alternative and Complementary Medicine, 7(3), 213–218.  https://doi.org/10.1089/107555301300328070.CrossRefGoogle Scholar
  44. Walach, H. (2011). Placebo controls: Historical, methodological and general aspects. Philosophical Transactions of the Royal Society B: Biological Sciences, 366(1572), 1870–1878.  https://doi.org/10.1098/rstb.2010.0401.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.National Research CouncilRomeItaly
  2. 2.National Institute of Biomedical TechnologiesMilanItaly
  3. 3.Fondazione Umberto VeronesiMilanItaly
  4. 4.Dipartimento di Scienze Biomediche e Chirurgico SpecialisticheUniversità di FerraraFerraraItaly
  5. 5.Institute for Advanced StudyTechnische Universität MünchenMunichGermany

Personalised recommendations